Instagram Pages

Here you can access stories featured on our instagram page. Want more biosimilar news? Sign up for our weekly newsletter, delivered to your inbox every Wednesday here.

More Research Finds Low Awareness of Biosimilars Among Oncology Providers

NHS Provides Update on Biosimilar Adalimumab With a Focus on ISRs


ye on Pharma: Biocon Reports Its Highest-Ever Revenue and Profit Growth for Q3


eview Points to Nocebo Effect as a Cause of Higher Discontinuation Rates for Biosimilars

Coherus Settles With AbbVie, Sues Amgen, Over Biosimilar Adalimumab


ncreases in Insulin Prices Drove Spending Over 4 Years, Report Says


uropean Report Says M&As Affecting Biosimilars Need Scrutiny

Drugs Targeted by Biosimilars Are Responsible for Some of the Highest Hospital Spending

Sanctions Against Samsung BioLogics Suspended Pending Court Ruling


ales of Oncology Reference Products Far Outpace R&D Costs, Study Finds